CGAS and autoimmune disease: RU.521 can assist as a constituent for the progress of prospective autoimmune disease therapy.147 A new investigation discloses that acetylation adds to the regulation of cGAS activity and delivers a potential therapy for handling DNA‐mediated autoimmune diseases.148